KEGG   PATHWAY: dle05017
Entry
dle05017                    Pathway                                
Name
Spinocerebellar ataxia - Delphinapterus leucas (beluga whale)
Description
The autosomal dominant spinocerebellar ataxias (SCAs) are a group of progressive neurodegenerative diseases characterised by loss of balance and motor coordination due to the primary dysfunction of the cerebellum. Compelling evidence points to major aetiological roles for transcriptional dysregulation, protein aggregation and clearance, autophagy, the ubiquitin-proteasome system, alterations of calcium homeostasis, mitochondria defects, toxic RNA gain-of-function mechanisms and eventual cell death with apoptotic features of neurons during SCA disease progression.
Class
Human Diseases; Neurodegenerative disease
Pathway map
dle05017  Spinocerebellar ataxia
dle05017

Disease
H00063  Spinocerebellar ataxia (SCA)
Organism
Delphinapterus leucas (beluga whale) [GN:dle]
Gene
111162721  XBP1; LOW QUALITY PROTEIN: X-box-binding protein 1 [KO:K09027]
111162904  AFG3L2; AFG3-like protein 2 isoform X1 [KO:K08956] [EC:3.4.24.-]
111163530  GRIN2A; glutamate receptor ionotropic, NMDA 2A [KO:K05209]
111164028  GTF2B; transcription initiation factor IIB [KO:K03124]
111164181  PSMB5; proteasome subunit beta type-5 isoform X1 [KO:K02737] [EC:3.4.25.1]
111164612  PSMC2; 26S proteasome regulatory subunit 7 [KO:K03061]
111164624  RELN; reelin isoform X1 [KO:K06249] [EC:3.4.21.-]
111165259  MYOD1; myoblast determination protein 1 [KO:K09064]
111165265  PSMA1; proteasome subunit alpha type-1 [KO:K02725] [EC:3.4.25.1]
111165617  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
111165653  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
111165862  RB1CC1; RB1-inducible coiled-coil protein 1 isoform X1 [KO:K17589]
111165889  SLC25A31; ADP/ATP translocase 4 [KO:K05863]
111165948  TBPL1; TATA box-binding protein-like protein 1 [KO:K03120]
111166150  MAP3K5; mitogen-activated protein kinase kinase kinase 5 isoform X1 [KO:K04426] [EC:2.7.11.25]
111166341  PSMD3; 26S proteasome non-ATPase regulatory subunit 3 [KO:K03033]
111166353  BECN1; beclin-1 isoform X1 [KO:K08334]
111166412  PSMB3; proteasome subunit beta type-3 [KO:K02735] [EC:3.4.25.1]
111166652  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
111166689  GRM1; metabotropic glutamate receptor 1 [KO:K04603]
111166710  SLC1A6; excitatory amino acid transporter 4 [KO:K05617]
111166727  CACNA1A; voltage-dependent P/Q-type calcium channel subunit alpha-1A isoform X1 [KO:K04344]
111167604  NRBF2; nuclear receptor-binding factor 2 [KO:K21246]
111167760  ULK2; serine/threonine-protein kinase ULK2 isoform X1 [KO:K08269] [EC:2.7.11.1]
111168028  TBP; TATA-box-binding protein [KO:K03120]
111168047  PSMB1; proteasome subunit beta type-1 [KO:K02732] [EC:3.4.25.1]
111168108  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
111168155  PIK3R4; phosphoinositide 3-kinase regulatory subunit 4 [KO:K08333] [EC:2.7.11.1]
111168252  GRIA3; glutamate receptor 3 isoform X1 [KO:K05199]
111168263  SLC25A6; ADP/ATP translocase 3 [KO:K05863]
111168878  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 isoform X1 [KO:K00914] [EC:2.7.1.137]
111169059  SLC25A5; ADP/ATP translocase 2 [KO:K05863]
111169265  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
111169718  PSMD4; 26S proteasome non-ATPase regulatory subunit 4 isoform X1 [KO:K03029]
111169730  PSMB4; proteasome subunit beta type-4 [KO:K02736] [EC:3.4.25.1]
111169895  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
111170282  PSMD13; 26S proteasome non-ATPase regulatory subunit 13 [KO:K03039]
111170348  WIPI2; WD repeat domain phosphoinositide-interacting protein 2 isoform X1 [KO:K17908]
111170472  GRIN3B; glutamate receptor ionotropic, NMDA 3B isoform X1 [KO:K05214]
111170864  [KO:K06053]
111171923  PSMD1; 26S proteasome non-ATPase regulatory subunit 1 isoform X1 [KO:K03032]
111172383  TWNK; twinkle protein, mitochondrial isoform X1 [KO:K17680] [EC:5.6.2.3]
111172522  OPA1; dynamin-like 120 kDa protein, mitochondrial isoform X1 [KO:K17079] [EC:3.6.5.5]
111172793  PSMD14; 26S proteasome non-ATPase regulatory subunit 14 isoform X1 [KO:K03030]
111172911  [KO:K08738]
111173114  PSMA3; proteasome subunit alpha type-3 isoform X1 [KO:K02727] [EC:3.4.25.1]
111173130  ATG14; beclin 1-associated autophagy-related key regulator isoform X2 [KO:K17889]
111173152  PSMC6; 26S proteasome regulatory subunit 10B [KO:K03064]
111173226  PSMA6; proteasome subunit alpha type-6 isoform X1 [KO:K02730] [EC:3.4.25.1]
111173238  PSMD2; 26S proteasome non-ATPase regulatory subunit 2 [KO:K03028]
111173316  TBPL2; TATA box-binding protein-like protein 2 [KO:K03120]
111173410  SLC25A4; ADP/ATP translocase 1 [KO:K05863]
111173555  VDAC3; voltage-dependent anion-selective channel protein 3 [KO:K15041]
111173839  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
111173942  SP1; transcription factor Sp1 [KO:K04684]
111173978  ATG101; autophagy-related protein 101 [KO:K19730]
111174031  [KO:K08738]
111174169  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
111174197  [KO:K08738]
111174220  PSMD6; 26S proteasome non-ATPase regulatory subunit 6 isoform X1 [KO:K03037]
111174571  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
111174575  [KO:K08738]
111174633  VLDLR; very low-density lipoprotein receptor isoform X1 [KO:K20053]
111175036  PUM2; pumilio homolog 2 isoform X1 [KO:K17943]
111175110  [KO:K21246]
111175485  PUM1; pumilio homolog 1 isoform X1 [KO:K17943]
111175568  PSMB2; proteasome subunit beta type-2 isoform X1 [KO:K02734] [EC:3.4.25.1]
111175760  [KO:K02649]
111175866  DAB1; disabled homolog 1 isoform X1 [KO:K20054]
111175868  OMA1; metalloendopeptidase OMA1, mitochondrial isoform X1 [KO:K23010]
111175930  [KO:K08738]
111176008  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
111176104  ATG2B; autophagy-related protein 2 homolog B isoform X1 [KO:K17906]
111176151  ATXN3; ataxin-3 isoform X1 [KO:K11863] [EC:3.4.22.-]
111176166  PSMC1; 26S proteasome regulatory subunit 4 isoform X1 [KO:K03062]
111176414  FGF14; fibroblast growth factor 14 isoform X1 [KO:K23920]
111176787  GRIN2B; glutamate receptor ionotropic, NMDA 2B [KO:K05210]
111176861  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959]
111176991  GRIN1; glutamate receptor ionotropic, NMDA 1 isoform X1 [KO:K05208]
111177009  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
111177231  PSMB7; proteasome subunit beta type-7 [KO:K02739] [EC:3.4.25.1]
111177424  BECN2; beclin-2 [KO:K08334]
111177559  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
111177681  RORA; nuclear receptor ROR-alpha isoform X1 [KO:K08532]
111177869  PSMA4; proteasome subunit alpha type-4 [KO:K02728] [EC:3.4.25.1]
111178692  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1 [KO:K04960]
111178791  NFYA; nuclear transcription factor Y subunit alpha isoform X1 [KO:K08064]
111179014  GRIA2; glutamate receptor 2 isoform X1 [KO:K05198]
111179235  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
111179377  [KO:K08956] [EC:3.4.24.-]
111179556  ATXN1L; ataxin-1-like [KO:K23616]
111179575  PSMD7; 26S proteasome non-ATPase regulatory subunit 7 [KO:K03038]
111179676  [KO:K19324]
111180031  KCND3; potassium voltage-gated channel subfamily D member 3 isoform X1 [KO:K04893]
111180078  PSMA5; proteasome subunit alpha type-5 [KO:K02729] [EC:3.4.25.1]
111180543  [KO:K08738]
111180666  GRIN2D; LOW QUALITY PROTEIN: glutamate receptor ionotropic, NMDA 2D [KO:K05212]
111180812  CIC; LOW QUALITY PROTEIN: protein capicua homolog [KO:K20225]
111180855  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
111180860  PSMC4; 26S proteasome regulatory subunit 6B [KO:K03063]
111180892  RYR1; LOW QUALITY PROTEIN: ryanodine receptor 1 [KO:K04961]
111180900  PSMD8; 26S proteasome non-ATPase regulatory subunit 8 [KO:K03031]
111180981  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
111181061  KCNC3; potassium voltage-gated channel subfamily C member 3 isoform X1 [KO:K04889]
111181329  SEM1; 26S proteasome complex subunit SEM1 isoform X1 [KO:K10881]
111181386  ATXN1; ataxin-1 [KO:K23616]
111181484  PSMA8; proteasome subunit alpha-type 8 [KO:K02731] [EC:3.4.25.1]
111181753  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
111182193  ATXN2L; ataxin-2-like protein isoform X1 [KO:K23625]
111182199  ATP2A1; sarcoplasmic/endoplasmic reticulum calcium ATPase 1 isoform X1 [KO:K05853] [EC:7.2.2.10]
111182232  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
111182441  VDAC1; voltage-dependent anion-selective channel protein 1 [KO:K05862]
111182616  PSMC5; 26S proteasome regulatory subunit 8 [KO:K03066]
111182623  ERN1; serine/threonine-protein kinase/endoribonuclease IRE1 [KO:K08852] [EC:2.7.11.1 3.1.26.-]
111182644  PSMD12; 26S proteasome non-ATPase regulatory subunit 12 [KO:K03035]
111182859  GRIN2C; glutamate receptor ionotropic, NMDA 2C isoform X1 [KO:K05211]
111182905  WIPI1; WD repeat domain phosphoinositide-interacting protein 1 isoform X1 [KO:K17908]
111182917  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
111183125  GRIA1; glutamate receptor 1 isoform X1 [KO:K05197]
111183499  MCU; calcium uniporter protein, mitochondrial isoform X1 [KO:K20858]
111183542  VDAC2; voltage-dependent anion-selective channel protein 2 [KO:K15040]
111183554  PPIF; peptidyl-prolyl cis-trans isomerase F, mitochondrial [KO:K09565] [EC:5.2.1.8]
111183696  SPTBN2; spectrin beta chain, non-erythrocytic 2 isoform X1 [KO:K23932]
111183743  KAT5; histone acetyltransferase KAT5 isoform X1 [KO:K11304] [EC:2.3.1.48]
111183789  ATG2A; autophagy-related protein 2 homolog A isoform X1 [KO:K17906]
111183812  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
111183961  PSMC3; 26S proteasome regulatory subunit 6A isoform X1 [KO:K03065]
111183977  ATG13; autophagy-related protein 13 isoform X1 [KO:K08331]
111183981  AMBRA1; activating molecule in BECN1-regulated autophagy protein 1 isoform X1 [KO:K17985]
111184364  PDYN; proenkephalin-B [KO:K15840]
111184370  NOP56; nucleolar protein 56 [KO:K14564]
111184415  RBPJL; recombining binding protein suppressor of hairless-like protein [KO:K06053]
111184500  PSMA2; proteasome subunit alpha type-2 [KO:K02726] [EC:3.4.25.1]
111185761  PSMD11; 26S proteasome non-ATPase regulatory subunit 11 [KO:K03036]
111185895  ATP2A3; sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform X1 [KO:K05853] [EC:7.2.2.10]
111185965  PSMB6; proteasome subunit beta type-6 [KO:K02738] [EC:3.4.25.1]
111185984  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
111186116  TRPC3; short transient receptor potential channel 3 isoform X2 [KO:K04966]
111186433  ATXN10; ataxin-10 isoform X1 [KO:K19323]
111186806  PSMA7; proteasome subunit alpha type-7 [KO:K02731] [EC:3.4.25.1]
111186817  ADRM1; proteasomal ubiquitin receptor ADRM1 [KO:K06691]
111186827  ULK1; serine/threonine-protein kinase ULK1 isoform X1 [KO:K21357] [EC:2.7.11.1]
111186839  PSMD9; 26S proteasome non-ATPase regulatory subunit 9 isoform X1 [KO:K06693]
111186871  ATXN2; ataxin-2 isoform X2 [KO:K23625]
111186914  ATP2A2; sarcoplasmic/endoplasmic reticulum calcium ATPase 2 [KO:K05853] [EC:7.2.2.10]
111187262  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
111187265  MTOR; serine/threonine-protein kinase mTOR isoform X1 [KO:K07203] [EC:2.7.11.1]
111187864  [KO:K15041]
111188066  GRIN3A; glutamate receptor ionotropic, NMDA 3A [KO:K05213]
Compound
C00025  L-Glutamate
C00076  Calcium cation
C00165  Diacylglycerol
C00238  Potassium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C04549  1-Phosphatidyl-1D-myo-inositol 3-phosphate
Reference
  Authors
Matilla-Duenas A, Sanchez I, Corral-Juan M, Davalos A, Alvarez R, Latorre P
  Title
Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
  Journal
Cerebellum 9:148-66 (2010)
DOI:10.1007/s12311-009-0144-2
Reference
  Authors
Duenas AM, Goold R, Giunti P
  Title
Molecular pathogenesis of spinocerebellar ataxias.
  Journal
Brain 129:1357-70 (2006)
DOI:10.1093/brain/awl081
Reference
  Authors
Mark MD, Schwitalla JC, Groemmke M, Herlitze S
  Title
Keeping Our Calcium in Balance to Maintain Our Balance.
  Journal
Biochem Biophys Res Commun 483:1040-1050 (2017)
DOI:10.1016/j.bbrc.2016.07.020
Reference
  Authors
Egorova PA, Bezprozvanny IB
  Title
Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders.
  Journal
FEBS J 285:3547-3565 (2018)
DOI:10.1111/febs.14366
Reference
  Authors
Shimobayashi E, Kapfhammer JP
  Title
Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
  Journal
Curr Neuropharmacol 16:151-159 (2018)
DOI:10.2174/1570159X15666170529104000
Reference
  Authors
Kasumu A, Bezprozvanny I
  Title
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
  Journal
Cerebellum 11:630-9 (2012)
DOI:10.1007/s12311-010-0182-9
Reference
  Authors
Egorova P, Popugaeva E, Bezprozvanny I
  Title
Disturbed calcium signaling in spinocerebellar ataxias and Alzheimer's disease.
  Journal
Semin Cell Dev Biol 40:127-33 (2015)
DOI:10.1016/j.semcdb.2015.03.010
Reference
  Authors
Hisatsune C, Hamada K, Mikoshiba K
  Title
Ca(2+) signaling and spinocerebellar ataxia.
  Journal
Biochim Biophys Acta Mol Cell Res 1865:1733-1744 (2018)
DOI:10.1016/j.bbamcr.2018.05.009
Reference
  Authors
Takada SH, Ikebara JM, de Sousa E, Cardoso DS, Resende RR, Ulrich H, Ruckl M, Rudiger S, Kihara AH
  Title
Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.
  Journal
Mol Neurobiol 54:6870-6884 (2017)
DOI:10.1007/s12035-016-0205-8
Reference
  Authors
Brown SA, Loew LM
  Title
Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.
  Journal
Front Neurosci 8:453 (2014)
DOI:10.3389/fnins.2014.00453
Reference
  Authors
Inoue T
  Title
Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cell.
  Journal
Keio J Med 52:244-9 (2003)
DOI:10.2302/kjm.52.244
Reference
  Authors
Adachi N, Kobayashi T, Takahashi H, Kawasaki T, Shirai Y, Ueyama T, Matsuda T, Seki T, Sakai N, Saito N
  Title
Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.
  Journal
J Biol Chem 283:19854-63 (2008)
DOI:10.1074/jbc.M801492200
Reference
  Authors
Smeets CJ, Jezierska J, Watanabe H, Duarri A, Fokkens MR, Meijer M, Zhou Q, Yakovleva T, Boddeke E, den Dunnen W, van Deursen J, Bakalkin G, Kampinga HH, van de Sluis B, Verbeek DS
  Title
Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.
  Journal
Brain 138:2537-52 (2015)
DOI:10.1093/brain/awv195
Reference
  Authors
Tulli S, Del Bondio A, Baderna V, Mazza D, Codazzi F, Pierson TM, Ambrosi A, Nolte D, Goizet C, Toro C, Baets J, Deconinck T, DeJonghe P, Mandich P, Casari G, Maltecca F
  Title
Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
  Journal
J Med Genet 56:499-511 (2019)
DOI:10.1136/jmedgenet-2018-105766
Reference
  Authors
Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolo V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F
  Title
Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
  Journal
Neurobiol Dis 124:14-28 (2019)
DOI:10.1016/j.nbd.2018.10.018
Reference
  Authors
Becker EBE
  Title
From Mice to Men: TRPC3 in Cerebellar Ataxia.
  Journal
Cerebellum 16:877-879 (2017)
DOI:10.1007/s12311-015-0663-y
Reference
  Authors
Hoxha E, Tempia F, Lippiello P, Miniaci MC
  Title
Modulation, Plasticity and Pathophysiology of the Parallel Fiber-Purkinje Cell Synapse.
  Journal
Front Synaptic Neurosci 8:35 (2016)
DOI:10.3389/fnsyn.2016.00035
Reference
  Authors
Yan H, Pablo JL, Pitt GS
  Title
FGF14 regulates presynaptic Ca2+ channels and synaptic transmission.
  Journal
Cell Rep 4:66-75 (2013)
DOI:10.1016/j.celrep.2013.06.012
Reference
  Authors
Tada M, Nishizawa M, Onodera O
  Title
Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.
  Journal
Neurochem Int 94:1-8 (2016)
DOI:10.1016/j.neuint.2016.01.007
Reference
  Authors
Pietrobon D
  Title
CaV2.1 channelopathies.
  Journal
Pflugers Arch 460:375-93 (2010)
DOI:10.1007/s00424-010-0802-8
Reference
  Authors
Matsuyama Z, Yanagisawa NK, Aoki Y, Black JL 3rd, Lennon VA, Mori Y, Imoto K, Inuzuka T
  Title
Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.
  Journal
Neurobiol Dis 17:198-204 (2004)
DOI:10.1016/j.nbd.2004.07.013
Reference
  Authors
Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H
  Title
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats.
  Journal
Genes Dev 16:1345-55 (2002)
DOI:10.1101/gad.992302
Reference
  Authors
Evers MM, Toonen LJ, van Roon-Mom WM
  Title
Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
  Journal
Mol Neurobiol 49:1513-31 (2014)
DOI:10.1007/s12035-013-8596-2
Reference
  Authors
Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC
  Title
Polyglutamine tracts regulate autophagy.
  Journal
Autophagy 13:1613-1614 (2017)
DOI:10.1080/15548627.2017.1336278
Reference
  Authors
Chen RH, Chen YH, Huang TY
  Title
Ubiquitin-mediated regulation of autophagy.
  Journal
J Biomed Sci 26:80 (2019)
DOI:10.1186/s12929-019-0569-y
Reference
  Authors
Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, Zoghbi HY, Clark HB, Andresen JM, Orr HT
  Title
RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.
  Journal
Cell 127:697-708 (2006)
DOI:10.1016/j.cell.2006.09.036
Reference
  Authors
Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajic A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT
  Title
ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
  Journal
Neuron 97:1235-1243.e5 (2018)
DOI:10.1016/j.neuron.2018.02.013
Reference
  Authors
Jimenez G, Shvartsman SY, Paroush Z
  Title
The Capicua repressor--a general sensor of RTK signaling in development and disease.
  Journal
J Cell Sci 125:1383-91 (2012)
DOI:10.1242/jcs.092965
Reference
  Authors
Gennarino VA, Palmer EE, McDonell LM, Wang L, Adamski CJ, Koire A, See L, Chen CA, Schaaf CP, Rosenfeld JA, Panzer JA, Moog U, Hao S, Bye A, Kirk EP, Stankiewicz P, Breman AM, McBride A, Kandula T, Dubbs HA, Macintosh R, Cardamone M, Zhu Y, Ying K, Dias KR, Cho MT, Henderson LB, Baskin B, Morris P, Tao J, Cowley MJ, Dinger ME, Roscioli T, Caluseriu O, Suchowersky O, Sachdev RK, Lichtarge O, Tang J, Boycott KM, Holder JL Jr, Zoghbi HY
  Title
A Mild PUM1 Mutation Is Associated with Adult-Onset Ataxia, whereas Haploinsufficiency Causes Developmental Delay and Seizures.
  Journal
Cell 172:924-936.e11 (2018)
DOI:10.1016/j.cell.2018.02.006
Reference
  Authors
Irie T, Matsuzaki Y, Sekino Y, Hirai H
  Title
Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.
  Journal
J Physiol 592:229-47 (2014)
DOI:10.1113/jphysiol.2013.264309
Reference
  Authors
Bushart DD, Murphy GG, Shakkottai VG
  Title
Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.
  Journal
Ann Transl Med 4:25 (2016)
DOI:10.3978/j.issn.2305-5839.2016.01.06
Reference
  Authors
Hsiao CT, Fu SJ, Liu YT, Lu YH, Zhong CY, Tang CY, Soong BW, Jeng CJ
  Title
Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.
  Journal
Hum Mutat 40:2088-2107 (2019)
DOI:10.1002/humu.23865
Reference
  Authors
Duarri A, Lin MC, Fokkens MR, Meijer M, Smeets CJ, Nibbeling EA, Boddeke E, Sinke RJ, Kampinga HH, Papazian DM, Verbeek DS
  Title
Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
  Journal
Cell Mol Life Sci 72:3387-99 (2015)
DOI:10.1007/s00018-015-1894-2
Reference
  Authors
Matilla-Duenas A, Volpini V
  Title
Spinocerebellar Ataxia Type 37
  Journal
GeneReviews (1993)
Reference
  Authors
Corral-Juan M, Serrano-Munuera C, Rabano A, Cota-Gonzalez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Mendez-Del-Barrio C, Jesus S, Mir P, Volpini V, Alvarez-Ramo R, Sanchez I, Matilla-Duenas A
  Title
Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
  Journal
Brain 141:1981-1997 (2018)
DOI:10.1093/brain/awy137
Reference
  Authors
Swinnen B, Robberecht W, Van Den Bosch L
  Title
RNA toxicity in non-coding repeat expansion disorders.
  Journal
EMBO J e101112 (2019)
DOI:10.15252/embj.2018101112
Reference
  Authors
Ishikawa K, Nagai Y
  Title
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31).
  Journal
Neurotherapeutics 10.1007/s13311-019-00804-6 (2019)
DOI:10.1007/s13311-019-00804-6
Reference
  Authors
Niimi Y, Takahashi M, Sugawara E, Umeda S, Obayashi M, Sato N, Ishiguro T, Higashi M, Eishi Y, Mizusawa H, Ishikawa K
  Title
Abnormal RNA structures (RNA foci) containing a penta-nucleotide repeat (UGGAA)n in the Purkinje cell nucleus is associated with spinocerebellar ataxia type 31 pathogenesis.
  Journal
Neuropathology 33:600-11 (2013)
DOI:10.1111/neup.12032
Reference
  Authors
Kobayashi H, Abe K, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, Habu T, Liu W, Okuda H, Koizumi A
  Title
Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement.
  Journal
Am J Hum Genet 89:121-30 (2011)
DOI:10.1016/j.ajhg.2011.05.015
Related
pathway
dle03050  Proteasome
dle04020  Calcium signaling pathway
dle04140  Autophagy - animal
dle04141  Protein processing in endoplasmic reticulum
dle04210  Apoptosis
dle04724  Glutamatergic synapse
dle04730  Long-term depression
KO pathway
ko05017   

DBGET integrated database retrieval system